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Objective: To create a nationally-representative estimate from longitudinal data by controlling for 
sociodemographic factors and health status.
Method: The Agency for Healthcare Research and Quality’s (AHRQ) Medicare Expenditures Panel Survey 
(MEPS) was used as the basis for adjustment methodology. MEPS is a data source representing health insurance 
coverage cost and utilization, and comprises several large-scale surveys of  families, individuals, employers, 
and health care providers. Using these data, we created subset populations. We then used multivariate logistic 
regression to construct demographics and case-mix-based weights, which were applied to create a population 
sample that is similar to the national population. The weight was derived using the inverse probability of  the 
weighting approach, as well as a raking mechanism. We compared the results with the projected number of  
persons in the US population in the same categories to examine the validity of  the weights.
Results: The following variables were used in the logistic regression: Age group, gender, race, location, income 
level and health status (Charlson Comorbidity Index scores and chronic condition diagnosis). Relative to MEPS 
data, patients included in the private insurance data were more likely to be male, older, to have a chronic 
condition, and to be white (p=0.0000). Adjusted weighted values for patients in the commercial group ranged 
from 15.47 to 36.36 (median: 16.91). Commercial insurance and MEPS data populations were similar in terms 
of  their socioeconomic and clinical categories. As an outcomes measure, the predicted annual number of  
patients with prescription claims from private insurance data was 6 963 034. The annual number of  statin users 
were predicted as 6 709 438 using weighted MEPS data.
Conclusion: National projections of  large-scale patient longitudinal databases require adjustment utilizing 
demographic factors and case-mix differences related to health status.
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INTRODUCTION
When researchers ask for a nationally-representative sample, they mean that the population of  interest is 
equivalent to the entire population of  the country in question, and the sample should reflect this in its structure. 
A nationally-representative sample should match the number of  men versus women according to national 
proportions, and the percentage in each age group or region should match the population. In outcomes research, 
matching based on health status is also crucial.
The first step for any sampling project is to identify the “universe” or “target population” of  subjects for which 
inferences are desired.1 Most data in outcomes research (i.e. commercial insurance claims data, regional trial 
datasets) may contain subsets of  the target population in proportions that do not match the ratios of  those 
groups in the population itself. Figure 1 presents the regional distribution of  a commercial insurance claims 
data population relative to the US national population. The data is underrepresented in the West and Midwest 
United States, but is overrepresented in the South and Northeast. Conversely, in the Medicare advantage 
population, the data is overrepresentative in West and underrepresentative in the others.
Figure 1. Regional Distribution of  Commercial Insurance Claims Data relative to National Data Affiliated
Health Plans, Commercially Insured Population with Medical and Pharmacy Benefits2,*,†
*Statistics current through December 31, 2014.
†Members counted here may also be counted in other administrative segments because they can move between segments over time. 
Members do not appear in multiple administrative segments during the same period of  time.
‡Includes members enrolled at any time in 2014.
§Excludes members where attribute is unknown.
||Source of  estimate of  US commercially insured population: US Census Bureau, Current Population Survey, Annual Social and 
Economic Supplement, 2014. Health insurance questions asked respondents about their status in the previous year (2013). Accessed 
at http://www.census.gov/cps/data/cpstablecreator.html.
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Figure 2 shows the distribution by age group. Among certain age groups, there are significant differences 
between the two data populations.
Figure 2. Age Distribution Comparison between Commercial and National Databases2,*,†
*Statistics current through December 31, 2014.
†Members counted here may also be counted in other administrative segments because they can move between segments over time. 
Members do not appear in multiple administrative segments during the same period of  time.
‡Includes members enrolled at any time in 2014.
§Excludes members where attribute is unknown.
||Source of  estimate of  US commercially insured population: US Census Bureau, Current Population Survey, Annual Social and 
Economic Supplement, 2014. Health insurance questions asked respondents about their status in the previous year (2013). Accessed 
at http://www.census.gov/cps/data/cpstablecreator.html.
In such situations, one can often improve the relationship between the sample and the population by creating 
weights based on specified characteristics that agree with the corresponding totals for the population.3
One way to create weights is to match each cell defined by the cross-classification of  categorical variables to 
control data which is usually chosen from a national data source. However, to make an argument that the sample 
represents the national population, adjustment for case-mix differences is necessary, since simple adjustment for 
demographics would not be adequate. For non-demographic measures (i.e. comorbid and chronic conditions) 
the sample should also match the population.
We analyzed the difference between a commercial insurance dataset and the household component of  the 
Agency for Healthcare Research and Quality (AHRQ) Medicare Expenditures Panel Survey (MEPS) in terms 
of  demographic factors and health status. We attempted to improve the estimates from the commercial 
dataset by creating weights for each case patient, so that marginal totals of  the adjusted weights agree with 
the corresponding totals (demographic and non-demographic) for the population according to specified 
characteristics. This operation is known as raking — an analogy for raking is the process of  smoothing the 
soil in a garden plot by working it back and forth with a rake in two perpendicular directions. The statistical 
procedure is discussed in detail by Bishop, et al.5 and Deming.6
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METHODS
A commercial multi-source patient longitudinal database and the household component of  the MEPS data 
provided the two data sources for this study.
The commercial dataset has a proprietary research database containing claims and enrollment data dating back 
to 2000 with the ability to link patient and physician survey data to pharmacy and medical claims, medical 
record data, socioeconomic measures, and clinical laboratory results. For 2005, data relating to approximately 
14 million individuals with both medical and pharmacy benefit coverage are available. Underlying information 
is geographically diverse across the United States and is frequently updated. The household component of  
MEPS collects data from a sample of  families and individuals in selected communities across the United States 
drawn from a nationally-representative sub-sample of  households that participated in the prior year’s National 
Health Interview Survey. For 2005, data relating to 32 320 individuals are available.
The socioeconomic characteristics included in the model were: Head of  the household age, female patient 
percentage, race, US geographic region, and income level.
We derived two variables to capture general health status of  the member. First, Charlson Comorbidity Index 
(CCI) scores were generated to capture the level and burden of  comorbidity. The most commonly used index 
in health outcomes studies is the CCI, which assigns a weight ranging from 1 to 6 according to disease severity 
for 19 conditions.7 The CCI contents and weighting scheme are based on Cox proportional hazards modeling.8 
The weights for each condition are summed, and a score is assigned to each patient. The original index was 
developed in an inpatient setting, using medical review to predict the risk of  mortality. The index has since 
adopted several weights, some of  which allow outpatient diagnoses to contribute to the score.9,10 Regardless of  
the version, the CCI has practically insignificant effects in predicting health care utility and indices.11,12
Secondly, we created an indicator variable to represent patients with chronic conditions. This variable was 
derived by convening two physician panels to review all medical conditions reported by the survey sample.
Our model proceeds in three steps using inverse probability weighting and raking strategy. Initial sampling 
weights were calculated as the inverse of  the probability of  selection. These weights play a pivotal role in 
design-based inferences to yield estimates that are intended to be unbiased and consistent. Finally the initial 
weights were adjusted so that the marginal total of  adjusted weight on specified characteristics agrees with the 
corresponding totals for the population.
The basic raking algorithm with two variables such as age and gender can be described as follows:
Let {ηi :i = 1,...,n} denote our initial weight estimated from the second step for sample size n from the population. 
In a post-stratification that has J rows and K columns, let njk be the sum of  the ηi in cell (j,k).
Initial row and column totals of  the initial weights and population numbers are defined as ηj+, η+k, Pj+ and P+k 
respectively.
The first three steps of  the algorithm are 1 : w[1] = ηj,k;2 : w[2] = w[1]*(—) for each k within each j; and
3 :  w[3] = w[2] * — or each j within each k. In the iteration process, both row and column weights are adjusted.
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To validate the initial weights, the MEPS sample was randomly categorized into two groups: Training subsample 
and test sub-sample. Weights were calculated using the training sub-sample. The weighted means were estimated 
for each confounder from the commercial data. These values were then compared with the mean of  same 
variables from the MEPS test sub-sample.
Final weights (after raking) were validated by comparing the results with those for the projected number of  
people in the US population in each category.
RESULTS
Table 1 shows the results of  logistic regression to identify the differences between the commercial and MEPS 
populations, in terms of  socioeconomic and clinical factors. Patients in the commercial data population were 
more likely to be male, older, and white. The probability of  being in the commercial data sample was close to 
four times higher for patients diagnosed with chronic conditions.
Table 1. Socioeconomic and Clinical Factor Differences in Commercial and MEPS Data
95% CI
Variables Odds Ratio Lower Upper
Age in Years
Under 5 Reference
5-17 2.08 1.88 2.31
18-44 1.71 1.55 1.97
45-64 1.63 1.47 1.8
Sex 1.88
Male Reference
Female 0.94 0.9 0.99
Race/ethnicity
White Reference
Hispanic or Latino 0.55 0.52 0.59
Black-single race/not Hispanic 0.39 0.36 Table 2. Summary of  the Annual, Monthly 
and Quarterly Weights created to Project the US 
Population from a Commercial Dataset
0.41
Other 4.02 3.5 4.61
Asian/Pacific Islander-single race/not Hispanic 0.46 0.41 0.5
Poverty Status
Low income Reference
High income 11.16 10.53 11.82
Census Region
Northeast Reference
Midwest 1.15 1.07 1.23
South 2.28 2.13 2.43
West 1.15 1.07 1.23
Chronic
Non-Chronic Reference
Chronic 4.38 4.1 4.68
Charlson Comorbidity Index Score 0.61 0.55 0.68
CI: confidence interval
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Table 2 shows the summary of  annual, monthly, and quarterly weights after raking. These weights were used to 
project the US population from the commercial data population.
Table 2. Summary of  the Annual, Monthly and Quarterly Weights created to Project the US Population from 
a Commercial Dataset
Variable Minimum Maximum Mean Median
Annual 15.47 36.36 16.99 16.91
Month 1 15.14 35.59 16.63 16.55
Month 2 15.17 35.65 16.66 16.58
Month 3 15.27 35.90 16.78 16.70
Month 4 15.35 36.07 16.86 16.78
Month 5 15.43 36.27 16.95 16.87
Month 6 15.47 36.36 17.00 16.91
Month 7 15.59 36.65 17.13 17.05
Month 8 15.63 36.73 17.17 17.08
Month 9 15.63 36.74 17.17 17.09
Month 10 15.64 36.77 17.19 17.10
Month 11 15.65 36.78 17.19 17.11
Month 12 15.64 36.77 17.19 17.10
Quarter 1 15.23 35.80 16.74 16.65
Quarter 2 15.35 36.09 16.87 16.79
Quarter 3 15.53 36.50 17.06 16.98
Quarter 4 15.75 37.03 17.31 17.22
Table 3 shows the projected number of  people in the US population after applying the weights for both data 
sources. The differences in the predictions for each category (socioeconomic and clinical) were negligible.
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Total 183 033 183 033
Age (years)
Under 5 11 377 11 350
5-17 35 159 35 168
18-44 78 181 78 109
45-64 58 315 58 326
Sex
Male 91 322 91 323
Female 91 710 91 710
Race/Ethnicity
Hispanic or Latino 18 092 18 085
Black-single race/not Hispanic 18 593 18 598
White, other, 2 or more races/not Hispanic 137 742 137 746
Asian/Pacific Islander-single race/not Hispanic 8606 8603
Poverty status
Low income 27 653 27 656
High income 155 379 155 377
US Census Region
Northeast 35 213 35 204
Midwest 43 376 43 369
South 63 204 63 213
West 41 239 41 245
Chronic Disease
Non-Chronic 148 759 150 315
Chronic 34 263 32 718
MEPS: Medicare Expenditures Panel Survey
We also created weights to predict outcomes measures: Annual statin users and number of  statin prescriptions. 
Projected annual statin prescriptions for commercial population from commercial data were 53 412 217. The 
projections from quarterly weights are shown in Figure 3. Predicted annual statin users for the commercial 
health care insurance population from commercial data were 6 963 034. The number predicted using MEPS 
data with MEPS weight was 6 709 438. Projections from quarterly weights are shown in Figure 4.
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Figure 3. Projected Total Annual Number of  Statin Prescriptions using Quarterly Weights
Figure 4. Summary of  the Annual, Monthly and Quarterly Weights created to Project the US Population from 
the a Commercial Patient Population
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CONCLUSION
National projections of  large-scale patient longitudinal databases require adjustment utilizing demographic 
factors and case-mix differences related to health status. The differences between commercial data and the 
household component of  the MEPS, in terms of  demographic factors and health status, were examined. We 
incorporated these differences into our model to calculate weights and examined the validity of  the created 
weights. The created weights successfully balanced the population in terms of  comorbid and chronic conditions, 
and demographic factors.
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